Jupiter Neurosciences, Inc. (JUNS) Financial Statements
Jupiter Neurosciences, Inc. Financial Overview
Jupiter Neurosciences, Inc.'s market cap is currently $2.70M. The company's EPS TTM is $-19.33; its P/E ratio is -0.11; Jupiter Neurosciences, Inc. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 21.80K | $ 0.00 | $ 0.00 | $ 233.28K | $ 638.04K |
| Gross Profit | $ 17.57K | $ 0.00 | $ 0.00 | $ 233.28K | $ 638.04K |
| Operating Income | $ -8.91M | $ -3.09M | $ -3.87M | $ -3.43M | $ -3.91M |
| EBITDA | $ -8.58M | $ -2.19M | $ -4.56M | $ -4.22M | $ -4.09M |
| Net Income | $ -8.64M | $ -2.44M | $ -4.78M | $ -4.96M | $ -4.38M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 3.79M | $ 3.77M | $ 28.48K | $ 64.43K | $ 330.60K |
| Total Assets | $ 5.56M | $ 6.20M | $ 148.59K | $ 235.94K | $ 667.38K |
| Total Debt | $ 5.32M | $ 217.76K | $ 2.25M | $ 1.90M | $ 651.20K |
| Net Debt | $ 1.53M | $ -3.55M | $ 2.22M | $ 1.83M | $ 320.60K |
| Total Liabilities | $ 7.40M | $ 2.03M | $ 5.95M | $ 7.38M | $ 5.85M |
| Stockholders' Equity | $ -1.83M | $ 4.17M | $ -5.80M | $ -7.14M | $ -5.18M |
| Cash Flow | |||||
| Free Cash Flow | $ -5.41M | $ -3.91M | $ -480.95K | $ -1.25M | $ -1.74M |
| Operating Cash Flow | $ -5.41M | $ -3.91M | $ -480.95K | $ -1.25M | $ -1.74M |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 5.43M | $ 7.65M | $ 445.00K | $ 982.33K | $ 1.86M |
Currency in USD